Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer

Multicenter VOLTAGE-2 Phase II Trial Will Conduct Exploratory Biomarker Analysis Using Highly-Sensitive Genomic Platforms from Personalis

... | May 16, 2023

Related Keywords

Fremont ,California ,United States ,Richard Chen ,Hideaki Bando ,National Cancer Center Hospital East ,Research Secretariat ,Linkedin ,Department Of Gastroenterology ,National Cancer Center ,Nasdaq ,Twitter ,Ono Pharmaceutical Co Ltd ,Personalis Inc ,Personalis Immuno ,Executive Vice President ,Chief Medical Officer ,Assistant Chief ,Principal Investigator ,Personalis ,Nc Stock Exchange ,News ,Information ,Press Release ,Multicenter ,Hase ,Hi ,Trial ,Hill ,Conduct ,Exploratory ,Biomarker ,Analysis ,Sing ,Enomic ,Platforms ,Rom Psnl Us71535d1063 ,